Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Global Market Report 2025
Request Sample Buy Now
Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : September 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Global Market Report 2025

By Component (Software, Hardware, Services); By Technology (Machine Learning, Deep Learning, Natural Language Processing, Computer Vision, Other Technologies); By Deployment Mode (Cloud-Based, On-Premises); By Diagnosis Type (Genetic Disorders, Autoimmune Disorders, Metabolic Disorders, Infectious Diseases, Other Diagnosis Types); By End-User (Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Other End-Users); Subsegments:; By Software (Clinical Decision Support, Machine Learning Algorithms, Diagnostic Reporting Software); By Hardware (Sequencing Instruments, Laboratory Equipment, Computational Servers, Diagnostic Sensors); By Services (Consulting Services And Upgrades) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

• Artificial Intelligence (AI)-Powered Rare Disease Diagnosis market size has reached to $1.54 billion in 2024

• Expected to grow to $5.50 billion in 2029 at a compound annual growth rate (CAGR) of 28.9%

• Growth Driver: Increasing Prevalence Of Autoimmune Disorders Is Fueling The Growth Of The Market Due To Rising Demand For Early Diagnosis And Personalized Treatment

• Market Trend: Advancements In Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Unified Genomic Diagnostics And Innovative Solutions

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?

Artificial intelligence (AI)-powered rare disease diagnosis refers to the use of advanced algorithms and machine learning techniques to identify uncommon medical conditions with high accuracy. These systems analyze complex patient data, including genetic, clinical, and imaging information, to detect patterns that may be missed by traditional diagnostic methods.

The main components of artificial intelligence (AI)-powered rare disease diagnosis are software, hardware and services. Software is a collection of programs, data, and instructions that tell a computer or device how to perform specific tasks or operations. The multiple technologies are machine learning, deep learning, natural language processing, computer vision, and others. The different deployment modes are cloud-based and on-premises solutions. The various diagnosis types are genetic disorders, autoimmune disorders, metabolic disorders, infectious diseases, and others, and they are used by several end-users such as hospitals, diagnostic centers, research institutes, specialty clinics, and others.

Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Size and growth rate 2025 to 2029: Graph

What Is The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Size 2025 And Growth Rate?

The artificial intelligence (AI)-powered rare disease diagnosis market size has grown exponentially in recent years. It will grow from $1.54 billion in 2024 to $1.99 billion in 2025 at a compound annual growth rate (CAGR) of 29.1%. The growth in the historic period can be attributed to increasing adoption of artificial intelligence (AI) in healthcare, growing investment in rare disease research, rising awareness about early diagnosis, expansion of healthcare infrastructure, and growing government support for digital health.

What Is The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Growth Forecast?

The artificial intelligence (AI)-powered rare disease diagnosis market size is expected to see exponential growth in the next few years. It will grow to $5.50 billion in 2029 at a compound annual growth rate (CAGR) of 28.9%. The growth in the forecast period can be attributed to increasing integration of machine learning algorithms, rising demand for personalized medicine, growing collaboration between ai startups and hospitals, expansion of genomic data availability, increasing healthcare digitalization. Major trends in the forecast period include advancements in deep learning models, innovations in predictive diagnostics, developments in natural language processing for medical data, research and development in multi-omics integration, and continuous improvement in artificial intelligence (AI)-driven imaging technologies.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How the Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Segmented?

1) By Component: Software, Hardware, Services

2) By Technology: Machine Learning, Deep Learning, Natural Language Processing, Computer Vision, Other Technologies

3) By Deployment Mode: Cloud-Based, On-Premises

4) By Diagnosis Type: Genetic Disorders, Autoimmune Disorders, Metabolic Disorders, Infectious Diseases, Other Diagnosis Types

5) By End-User: Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Other End-Users

Subsegments:

1) By Software: Clinical Decision Support, Data Analytics Platforms, Genomic Interpretation Tools, Machine Learning Algorithms, Diagnostic Reporting Software

2) By Hardware: Sequencing Instruments, Imaging Devices, Laboratory Equipment, Computational Servers, Diagnostic Sensors

3) By Services: Consulting Services, Implementation And Integration, Training And Support, Data Management Services, Maintenance And Upgrades

What Is Driving The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market? Increasing Prevalence Of Autoimmune Disorders Is Fueling The Growth Of The Market Due To Rising Demand For Early Diagnosis And Personalized Treatment

The increasing prevalence of autoimmune disorders is expected to propel the growth of the artificial intelligence (AI)-powered rare disease diagnosis market going forward. Autoimmune disorders are conditions where the immune system mistakenly attacks the body’s own healthy cells and tissues, causing inflammation and damage. The prevalence of autoimmune disorders is due to the growing number of individuals experiencing immune system dysfunctions, leading to higher demand for early diagnosis, advanced treatments, and continuous monitoring to manage symptoms effectively. Artificial intelligence (AI)-powered rare disease diagnosis supports autoimmune disorders management by rapidly identifying complex conditions, supporting personalized treatment decisions, and improving overall diagnostic accuracy. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government organization, in 2022, an estimated 514,000 people (2.0%) in Australia were living with the rheumatoid arthritis (a systemic autoimmune disorder in which the body's immune system targets its tissues). Therefore, the increasing prevalence of autoimmune disorders drives the growth of the artificial intelligence (AI)-powered rare disease diagnosis industry.

Who Are The Major Players In The Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?

Major companies operating in the artificial intelligence (ai)-powered rare disease diagnosis market are Ambry Genetics Corporation, MedGenome Inc., Sophia Genetics SA, Variantyx Inc., Facial Dysmorphology Novel Analysis, Atropos Health Inc., Congenica Ltd., Saventic Care Sp. z o.o., Rapid Innovation LLC, Centogene N.V., Impilo AB, ThinkGenetic Inc., ClairLabs Ltd., 3billion Inc., OpenEvidence Inc., GenomeUp S.R.L., Mendel.ai Inc., RareSum GmbH, DeepRare AI Solutions, Zebra-Llama Project.

What Are The Key Trends Of The Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market? Advancements In Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Unified Genomic Diagnostics And Innovative Solutions

Major companies operating in the artificial intelligence (AI)-powered rare disease diagnosis market are focusing on developing innovative technology, such as unified genomic diagnostics solutions, to enhance diagnostic accuracy, reduce turnaround time, and provide more comprehensive insights into complex genetic disorders. A unified genomic diagnostics solution is an integrated system combining whole-genome sequencing and artificial intelligence (AI)-driven analysis to deliver complete genetic insights. For instance, in October 2023, Oxford Nanopore Technologies plc, a UK-based biotechnology company, and Fabric Genomics Inc., a US-based artificial intelligence (AI)-based company, launched an integrated whole-genome sequencing solution that aims to accelerate rare disease diagnosis by combining rapid sequencing with AI-driven variant interpretation for more accurate and actionable clinical insights. The launch integrates real-time nanopore sequencing with artificial intelligence (AI)-powered genomic analysis to rapidly identify rare genetic variants. It delivers comprehensive, actionable insights to clinicians, enhancing diagnostic speed and accuracy for pediatric care.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market? Mars Incorporated Acquires SYNLAB.Vet GmbH To Strengthen Global Veterinary Diagnostics Capabilities

In May 2022, Sema4, a US-based artificial intelligence-driven genomic and clinical data intelligence platform, acquired GeneDx Holdings Corp. for an undisclosed amount. With this acquisition, Sema4 aimed to strengthen its leadership in rare disease diagnostics by integrating GeneDx’s extensive genomic data resources with its AI-powered platforms to enhance diagnostic accuracy and accelerate personalized medicine. GeneDx Holdings Corp. is a US-based biotechnology and medical diagnostics company that uses genomics and artificial intelligence (AI) to diagnose rare genetic diseases.

What Is The Regional Outlook For The Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?

North America was the largest region in the artificial intelligence (AI)-powered rare disease diagnosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?

The artificial intelligence (AI)-powered rare disease diagnosis market includes revenues earned by entities by providing services such as genomic sequencing analysis, clinical data integration, artificial intelligence (AI)-based imaging interpretation, predictive analytics for rare diseases, and personalized treatment recommendations. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-powered rare disease diagnosis market also includes sales of genetic testing kits, imaging scanners, biosensors, lab automation instruments, point-of-care testing devices, wearable health monitors, sequencing machines, microfluidic chips, and pathology slide scanners. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Industry?

The artificial intelligence (ai)-powered rare disease diagnosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai)-powered rare disease diagnosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Artificial Intelligence AI Powered Rare Disease Diagnosis Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.99 billion
Revenue Forecast In 2034 $5.50 billion
Growth Rate CAGR of 29.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Component, Technology, Deployment Mode, Diagnosis Type, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Ambry Genetics Corporation, MedGenome Inc., Sophia Genetics SA, Variantyx Inc., Facial Dysmorphology Novel Analysis, Atropos Health Inc., Congenica Ltd., Saventic Care Sp. z o.o., Rapid Innovation LLC, Centogene N.V., Impilo AB, ThinkGenetic Inc., ClairLabs Ltd., 3billion Inc., OpenEvidence Inc., GenomeUp S.R.L., Mendel.ai Inc., RareSum GmbH, DeepRare AI Solutions, Zebra-Llama Project.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Characteristics

3. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Trends And Strategies

4. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Growth Analysis And Strategic Analysis Framework

5.1. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Growth Rate Analysis

5.4. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Total Addressable Market (TAM)

6. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Segmentation

6.1. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Software

Hardware

Services

6.2. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Machine Learning

Deep Learning

Natural Language Processing

Computer Vision

Other Technologies

6.3. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cloud-Based

On-Premises

6.4. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genetic Disorders

Autoimmune Disorders

Metabolic Disorders

Infectious Diseases

Other Diagnosis Types

6.5. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Diagnostic Centers

Research Institutes

Specialty Clinics

Other End-Users

6.6. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical Decision Support

Data Analytics Platforms

Genomic Interpretation Tools

Machine Learning Algorithms

Diagnostic Reporting Software

6.7. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sequencing Instruments

Imaging Devices

Laboratory Equipment

Computational Servers

Diagnostic Sensors

6.8. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Consulting Services

Implementation And Integration

Training And Support

Data Management Services

Maintenance And Upgrades

7. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Regional And Country Analysis

7.1. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

8.1. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

9.1. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

9.2. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

10.1. India Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

11.1. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

11.2. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

12.1. Australia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

13.1. Indonesia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

14.1. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

14.2. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

15.1. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

15.2. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

16.1. UK Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

17.1. Germany Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

18.1. France Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

19.1. Italy Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

20.1. Spain Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

21.1. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

21.2. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

22.1. Russia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

23.1. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

23.2. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

24.1. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

24.2. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

25.1. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

25.2. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

26.1. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

26.2. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

27.1. Brazil Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

28.1. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

28.2. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

29.1. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

29.2. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Competitive Landscape And Company Profiles

30.1. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Competitive Landscape

30.2. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Company Profiles

30.2.1. Ambry Genetics Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.2. MedGenome Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Sophia Genetics SA Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Variantyx Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Facial Dysmorphology Novel Analysis Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Other Major And Innovative Companies

31.1. Atropos Health Inc.

31.2. Congenica Ltd.

31.3. Saventic Care Sp. z o.o.

31.4. Rapid Innovation LLC

31.5. Centogene N.V.

31.6. Impilo AB

31.7. ThinkGenetic Inc.

31.8. ClairLabs Ltd.

31.9. 3billion Inc.

31.10. OpenEvidence Inc.

31.11. GenomeUp S.R.L.

31.12. Mendel.ai Inc.

31.13. RareSum GmbH

31.14. DeepRare AI Solutions

31.15. Zebra-Llama Project

32. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

34. Recent Developments In The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

35. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market High Potential Countries, Segments and Strategies

35.1 Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market In 2029 - Countries Offering Most New Opportunities

35.2 Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market In 2029 - Segments Offering Most New Opportunities

35.3 Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Ambry Genetics Corporation Financial Performance
  • Table 80: MedGenome Inc. Financial Performance
  • Table 81: Sophia Genetics SA Financial Performance
  • Table 82: Variantyx Inc. Financial Performance
  • Table 83: Facial Dysmorphology Novel Analysis Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Ambry Genetics Corporation Financial Performance
  • Figure 80: MedGenome Inc. Financial Performance
  • Figure 81: Sophia Genetics SA Financial Performance
  • Figure 82: Variantyx Inc. Financial Performance
  • Figure 83: Facial Dysmorphology Novel Analysis Financial Performance

Latest Market Developments in Ketamine Clinic Industry: Forecast 2025–2029

Read More About Latest Market Developments in Ketamine Clinic Industry: Forecast 2025–2029

Competitive and Market Trend Analysis of Lifestyle Diseases Apps Industry Through 2029

Read More About Competitive and Market Trend Analysis of Lifestyle Diseases Apps Industry Through 2029

Industry Trends Show Locum Tenens Staffing Market Set to Expand at 11.6% CAGR Until 2029

Read More About Industry Trends Show Locum Tenens Staffing Market Set to Expand at 11.6% CAGR Until 2029

In-Depth Lung Cancer Surgery Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Lung Cancer Surgery Market Report: Business Trends, Growth Factors, and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Read More About Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Automotive Films Market 2023 – By Film Type (Automotive Films Window Film, Paint Protection Films (PPF), Wrap Film), By Vehicle Type (Passenger, Commercial), By Application (Interior, Exterior ), By Material Type (Dyed, ...

View Report

Tax Management Market 2023 – By Component (Software, Services), By Deployment Mode (Cloud, On-Premises), By Vertical (Corporate Banking Financial Services And Insurance (BFSI), Information Technology (IT) And Telecom, Ma...

View Report

Physical Security Market 2025 - By Component (Systems, Services), By Organization Size (Small And Medium-Sized Enterprises (SMEs), Large Enterprises), By End User (Transportation, Government, Banking And Finance, Utility...

View Report

Pulse Oximeter Global Market Report 2025 – By Product Type (Fingertip, Handheld, Wrist-worn, Table-Top And Bedside), By Technology (Conventional, Connected), By Age Group (Adult, Pediatric), By End-User (Hospitals And Cl...

View Report

Crohn's Disease (CD) Treatment Global Market Report 2025 – By Drug Type (Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types), By Route of Administration (Oral, Injectable), By Distributio...

View Report

Tankless Water Heater Global Market Report 2025 – By Type (Condensing, Non-Condensing), By Energy Source (Electric, Gas), By Application (Residential, Commercial) – Impact of Tariff and Trade War on Market Size, Growth, ...

View Report

Frequently Asked Questions

Artificial intelligence (AI)-powered rare disease diagnosis refers to the use of advanced algorithms and machine learning techniques to identify uncommon medical conditions with high accuracy. These systems analyze complex patient data, including genetic, clinical, and imaging information, to detect patterns that may be missed by traditional diagnostic methods. For further insights on this market, request a sample here

The market major growth driver - Increasing Prevalence Of Autoimmune Disorders Is Fueling The Growth Of The Market Due To Rising Demand For Early Diagnosis And Personalized Treatment. For further insights on this market, request a sample here

The artificial intelligence (AI)-powered rare disease diagnosis market size has grown exponentially in recent years. It will grow from $1.54 billion in 2024 to $1.99 billion in 2025 at a compound annual growth rate (CAGR) of 29.1%. The growth in the historic period can be attributed to increasing adoption of artificial intelligence (AI) in healthcare, growing investment in rare disease research, rising awareness about early diagnosis, expansion of healthcare infrastructure, and growing government support for digital health. The artificial intelligence (AI)-powered rare disease diagnosis market size is expected to see exponential growth in the next few years. It will grow to $5.50 billion in 2029 at a compound annual growth rate (CAGR) of 28.9%. The growth in the forecast period can be attributed to increasing integration of machine learning algorithms, rising demand for personalized medicine, growing collaboration between ai startups and hospitals, expansion of genomic data availability, increasing healthcare digitalization. Major trends in the forecast period include advancements in deep learning models, innovations in predictive diagnostics, developments in natural language processing for medical data, research and development in multi-omics integration, and continuous improvement in artificial intelligence (AI)-driven imaging technologies. For further insights on this market, request a sample here

The artificial intelligence (AI)-powered rare disease diagnosis market covered in this report is segmented as
1) By Component: Software, Hardware, Services
2) By Technology: Machine Learning, Deep Learning, Natural Language Processing, Computer Vision, Other Technologies
3) By Deployment Mode: Cloud-Based, On-Premises
4) By Diagnosis Type: Genetic Disorders, Autoimmune Disorders, Metabolic Disorders, Infectious Diseases, Other Diagnosis Types
5) By End-User: Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Other End-Users Subsegments:
1) By Software: Clinical Decision Support, Data Analytics Platforms, Genomic Interpretation Tools, Machine Learning Algorithms, Diagnostic Reporting Software
2) By Hardware: Sequencing Instruments, Imaging Devices, Laboratory Equipment, Computational Servers, Diagnostic Sensors
3) By Services: Consulting Services, Implementation And Integration, Training And Support, Data Management Services, Maintenance And Upgrades For further insights on this market, request a sample here

North America was the largest region in the artificial intelligence (AI)-powered rare disease diagnosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-powered rare disease diagnosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the artificial intelligence (ai)-powered rare disease diagnosis market are Ambry Genetics Corporation, MedGenome Inc., Sophia Genetics SA, Variantyx Inc., Facial Dysmorphology Novel Analysis, Atropos Health Inc., Congenica Ltd., Saventic Care Sp. z o.o., Rapid Innovation LLC, Centogene N.V., Impilo AB, ThinkGenetic Inc., ClairLabs Ltd., 3billion Inc., OpenEvidence Inc., GenomeUp S.R.L., Mendel.ai Inc., RareSum GmbH, DeepRare AI Solutions, Zebra-Llama Project. For further insights on this market, request a sample here.

Major trends in this market include Advancements In Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Unified Genomic Diagnostics And Innovative Solutions For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top